Totally implantable central venous access ports for M/XDR-TB treatment

Conclusions: The study demonstrates high levels of patient acceptability and treatment adherence using TICVAP with reasonable level of safety. The experience gained can promote this approach for further expansion in programmatic settings.

Source: European Respiratory Journal - December 6, 2017 Category: Respiratory Medicine Authors: Skrahin, A., Pechinski, D., Makovski, N., Dobysh, K., Sinha, A., Kmyz, M., Hlushanina, H., Skrahina, A. Tags: Tuberculosis Source Type: research